Protective role of chrysin on 6-hydroxydopamine-induced neurodegeneration a mouse model of Parkinson's disease: Involvement of neuroinflammation and neurotrophins

被引:100
|
作者
Goes, Andre T. R. [1 ]
Jesse, Cristiano R. [1 ]
Antunes, Michelle S. [1 ]
Lobo Ladd, Fernando V. [2 ]
Lobo Ladd, Aliny A. B. [3 ]
Luchese, Cristiane [4 ]
Paroul, Natalia [5 ]
Boeira, Silvana P. [1 ]
机构
[1] Fed Univ Pampa, Lab Pharmacol & Toxicol Evaluat Appl Bioact Mol, BR-97650000 Itaqui, RS, Brazil
[2] Univ Fed Rio Grande do Norte, Dept Morphol, Lab Neuroanatom, Biosci Ctr, Natal, RN, Brazil
[3] Univ Sao Paulo, Lab Stochast Stereol & Chem Anat, Dept Surg, Coll Vet Med & Anim Sci, Sao Paulo, Brazil
[4] Univ Fed Pelotas, Ctr Ciencias Quim Farmaceut & Alimentos, Campus Univ S-N, BR-96160000 Capao Do Leao, RS, Brazil
[5] Univ Reg Integrada, Campus Erechim, BR-99700000 Erechim, RS, Brazil
关键词
Neurotrophic factor; Flavonoid; Inflammation; Dopamine; Neurodegenerative disease; DOPAMINERGIC-NEURONS; OXIDATIVE STRESS; COGNITIVE IMPAIRMENT; ALZHEIMERS-DISEASE; MOTOR IMPAIRMENTS; RAT MODEL; MICE; PROTEIN; BRAIN; SUPPRESSION;
D O I
10.1016/j.cbi.2017.10.019
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Chrysin is a natural flavonoid which is found in bee propolis, honey and various plants, and neuroprotective effect of chrysin in mice was previously demonstrated by our group. Neuroinflammation, neurotrophic factors and neuronal recovery factors associated with the neuroprotective effect of this flavonoid require further investigations. Thus, now we investigated the possible involvement of inflammatory cytokines, neurotrophic factors and neuronal recovery in the effect of chrysin in 6-hydroxidopamine (6-OHDA), a well-established model of Parkinson's disease, in striatum of mice. The 6-OHDA microinjection induced behavioral alterations on the rotarod test and apomorphine-induced circling behavior in mice. 6-OHDA administration elevated levels of tumour necrosis factor-a, interferon-gamma, interleukin-1 beta, interleukin-2, interleukin-6 and nuclear factor-kappa B and decreased the interleukin-10 levels, total reactive antioxidant potential and total antioxidant reactivity in striatum, as well as, modified the calcium-binding protein B (S100B), brain-derived neurotrophic factor, nerve growth factor and glial cell line-derived neurotrophic factor levels. The intrastriatal injection of 6-OHDA also induced an decrease of dopamine, 3,4-dihydroxyphenylacetic acid, homovanylic acid levels and tyrosine hydroxylase content. Oral treatment with chrysin (10 mg/kg, 28 days), culminated with the prevention of these alterations occasioned by 6-OHDA. These results corroborated with the neuroprotective effect of chrysin in the treatment of Parkinson's disease and, indicated the mechanism involved throught the inflammatory cytokines, neurotrophic factors and recovery of dopaminergic neurons in striatum.
引用
收藏
页码:111 / 120
页数:10
相关论文
共 50 条
  • [1] Protective effect of hesperidin in a model of Parkinson's disease induced by 6-hydroxydopamine in aged mice
    Antunes, Michelle S.
    Goes, Andre T. R.
    Boeira, Silvana P.
    Prigol, Marina
    Jesse, Cristiano R.
    NUTRITION, 2014, 30 (11-12) : 1415 - 1422
  • [2] TIME-COURSE OF NIGROSTRIATAL NEURODEGENERATION AND NEUROINFLAMMATION IN THE 6-HYDROXYDOPAMINE-INDUCED AXONAL AND TERMINAL LESION MODELS OF PARKINSON'S DISEASE IN THE RAT
    Walsh, S.
    Finn, D. P.
    Dowd, E.
    NEUROSCIENCE, 2011, 175 : 251 - 261
  • [3] MPTP and 6-hydroxydopamine-induced neurodegeneration as models for Parkinson’s disease: neuroprotective strategies
    E. Grünblatt
    S. Mandel
    M. B. H. Youdim
    Journal of Neurology, 2000, 247 (Suppl 2) : II95 - II102
  • [4] MPTP and 6-hydroxydopamine-induced neurodegeneration as models for Parkinson's disease:: neuroprotective strategies
    Grünblatt, E
    Mandel, S
    Youdim, MBH
    JOURNAL OF NEUROLOGY, 2000, 247 : 95 - 102
  • [5] Molecular hydrogen is protective against 6-hydroxydopamine-induced nigrostriatal degeneration in a rat model of Parkinson's disease
    Fu, Yuan
    Ito, Mikako
    Fujita, Yasunori
    Ito, Masafumi
    Ichihara, Masatoshi
    Masuda, Akio
    Suzuki, Yumi
    Maesawa, Satoshi
    Kajita, Yasukazu
    Hirayama, Masaaki
    Ohsawa, Ikuroh
    Ohta, Shigeo
    Ohno, Kinji
    NEUROSCIENCE LETTERS, 2009, 453 (02) : 81 - 85
  • [6] Loss of Collapsin Response Mediator Protein 4 Attenuates 6-Hydroxydopamine-Induced Impairments in a Mouse Model of Parkinson's Disease
    Li, Wenting
    Goshima, Yoshio
    Ohshima, Toshio
    NEUROCHEMICAL RESEARCH, 2020, 45 (10) : 2286 - 2301
  • [7] Protective effect of caffeine and/or taurine on the 6-hydroxydopamine-induced rat model of Parkinson's disease: Behavioral and neurochemical evidence
    Abuirmeileh, Amjad N.
    Abuhamdah, Sawsan M.
    Ashraf, Asser
    Alzoubi, Karem H.
    RESTORATIVE NEUROLOGY AND NEUROSCIENCE, 2021, 39 (02) : 149 - 157
  • [8] Neuroinflammation in Parkinson's disease: role in neurodegeneration and tissue repair
    Vivekanantham, Sayinthen
    Shah, Savan
    Dewji, Rizwan
    Dewji, Abbas
    Khatri, Chetan
    Ologunde, Rele
    INTERNATIONAL JOURNAL OF NEUROSCIENCE, 2015, 125 (10) : 717 - 725
  • [9] Apigenin alleviates neuroinflammation in a mouse model of Parkinson's disease
    Yarim, Gul Fatma
    Kazak, Filiz
    Yarim, Murat
    Sozmen, Mahmut
    Genc, Bugra
    Ertekin, Ali
    Gokceoglu, Ayris
    INTERNATIONAL JOURNAL OF NEUROSCIENCE, 2022,
  • [10] Longitudinal and parallel monitoring of neuroinflammation and neurodegeneration in a 6-hydroxydopamine rat model of Parkinson's disease
    Maia, Serge
    Arlicot, Nicolas
    Vierron, Emilie
    Bodard, Sylvie
    Vergote, Jackie
    Guilloteau, Denis
    Chalon, Sylvie
    SYNAPSE, 2012, 66 (07) : 573 - 583